DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,110 | +4.2% | 1,258 | +0.8% | 0.02% | +5.6% |
| Q2 2023 | $299,520 | +7.2% | 1,248 | +12.5% | 0.02% | +5.9% |
| Q1 2023 | $279,512 | +22.6% | 1,109 | +25.5% | 0.02% | +6.2% |
| Q3 2022 | $228,000 | -6.6% | 884 | -8.0% | 0.02% | 0.0% |
| Q2 2022 | $244,000 | -10.0% | 961 | +4.1% | 0.02% | -5.9% |
| Q1 2022 | $271,000 | +4.6% | 923 | +17.1% | 0.02% | +6.2% |
| Q4 2021 | $259,000 | +1.6% | 788 | -5.9% | 0.02% | -5.9% |
| Q3 2021 | $255,000 | +19.2% | 837 | +5.2% | 0.02% | +21.4% |
| Q2 2021 | $214,000 | -19.5% | 796 | -58.6% | 0.01% | -50.0% |
| Q1 2020 | $266,000 | +10.4% | 1,922 | +22.4% | 0.03% | +40.0% |
| Q4 2019 | $241,000 | -10.7% | 1,570 | -50.9% | 0.02% | -35.5% |
| Q2 2017 | $270,000 | -11.2% | 3,195 | -10.1% | 0.03% | -13.9% |
| Q1 2017 | $304,000 | -37.6% | 3,553 | -43.2% | 0.04% | -42.9% |
| Q4 2016 | $487,000 | -0.4% | 6,258 | +0.4% | 0.06% | -10.0% |
| Q3 2016 | $489,000 | -3.7% | 6,233 | +23.8% | 0.07% | -9.1% |
| Q2 2016 | $508,000 | +6.5% | 5,033 | 0.0% | 0.08% | +4.1% |
| Q1 2016 | $477,000 | +2.1% | 5,033 | 0.0% | 0.07% | -3.9% |
| Q4 2015 | $467,000 | +8.9% | 5,033 | 0.0% | 0.08% | 0.0% |
| Q3 2015 | $429,000 | +5.9% | 5,033 | +6.3% | 0.08% | +13.2% |
| Q2 2015 | $405,000 | +2.5% | 4,733 | +1.7% | 0.07% | +3.0% |
| Q1 2015 | $395,000 | +70.3% | 4,655 | +72.1% | 0.07% | +65.0% |
| Q4 2014 | $232,000 | +12.6% | 2,705 | 0.0% | 0.04% | +5.3% |
| Q3 2014 | $206,000 | -3.3% | 2,705 | 0.0% | 0.04% | -5.0% |
| Q2 2014 | $213,000 | – | 2,705 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |